Back

New pathogenic variants and insights into pathogenic mechanisms in GRK1-related Oguchi disease.

Poulter, J. A.; Gravett, M.; Taylor, R. L.; Fujinami, K.; De Zaeytijd, J.; Bellingham, J.; Hayashi, T.; Kondo, M.; Donnelly, D.; Toomes, C.; Ali, M.; UK Inherited Retinal Disease Consortium, ; Genomics England Research Consortium, ; De Baere, E.; Leroy, B. P.; Davies, N. P.; Webster, A. R.; Mahroo, O. A.; Arno, G.; Black, G. C.; McKibbin, M.; Harris, S. A.; Khan, K. N.; Inglehearn, C. F.

2020-02-20 genetics
10.1101/2020.02.20.936880 bioRxiv
Show abstract

PurposeBiallelic mutations in G-Protein coupled receptor kinase 1 (GRK1) cause Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB). The purpose of this study was to identify pathogenic GRK1 variants and use in-depth bioinformatic analyses to evaluate how their impact on protein structure could lead to pathogenicity. MethodsPatients genomic DNA was sequenced by whole genome, whole exome or focused exome sequencing. Pathogenic variants, published and novel, were compared to nondisease associated missense variants. The impact of GRK1 missense variants at the protein level were then predicted using a series of computational tools. ResultsWe identified eleven previously unpublished cases with biallelic pathogenic GRK1 variants, including seven novel variants, and reviewed all GRK1 pathogenic variants. Further structure-based scoring revealed a hotspot for missense variants in the kinase domain. Additionally, to aid future clinical interpretation, we identified the bioinformatics tools best able to differentiate pathogenic from non-pathogenic variants. ConclusionWe identified new GRK1 pathogenic variants in Oguchi disease patients and investigated how disease-causing variants may impede protein function, giving new insights into the mechanisms of pathogenicity. All pathogenic GRK1 variants described to date have been collated into a Leiden Open Variation Database (http://dna2.leeds.ac.uk/GRK1_LOVD/genes/GRK1).

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Medical Genetics
28 papers in training set
Top 0.1%
23.2%
2
Human Mutation
29 papers in training set
Top 0.1%
10.4%
3
European Journal of Human Genetics
49 papers in training set
Top 0.1%
7.4%
4
Genetics in Medicine
69 papers in training set
Top 0.2%
7.4%
5
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.1%
7.4%
50% of probability mass above
6
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.1%
6.5%
7
Scientific Reports
3102 papers in training set
Top 26%
4.4%
8
PLOS ONE
4510 papers in training set
Top 37%
3.7%
9
Frontiers in Medicine
113 papers in training set
Top 2%
3.2%
10
Genes
126 papers in training set
Top 0.7%
1.9%
11
Human Genetics
25 papers in training set
Top 0.1%
1.7%
12
Human Molecular Genetics
130 papers in training set
Top 2%
1.7%
13
Frontiers in Genetics
197 papers in training set
Top 4%
1.7%
14
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.6%
1.5%
15
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
1.4%
16
PLOS Genetics
756 papers in training set
Top 12%
1.0%
17
Neurology
44 papers in training set
Top 1%
0.9%
18
BMC Medical Genomics
36 papers in training set
Top 1%
0.8%
19
Gene Reports
13 papers in training set
Top 0.7%
0.7%
20
npj Genomic Medicine
33 papers in training set
Top 1%
0.7%
21
Translational Vision Science & Technology
35 papers in training set
Top 0.7%
0.5%
22
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.8%
0.5%
23
Life Science Alliance
263 papers in training set
Top 3%
0.5%
24
Disease Models & Mechanisms
119 papers in training set
Top 4%
0.5%
25
Frontiers in Neurology
91 papers in training set
Top 6%
0.5%
26
Clinical and Translational Medicine
30 papers in training set
Top 2%
0.5%